Kerr Corporation products

CaviCide is a convenient, ready-to-use, intermediate-level disinfectant which is effective against TB, HBV, HCV, HIV, viruses (hydrophilic and lipophilic), bacteria (including MRSA and VRE) and fungi. It can be used in all areas of the facility including ICU, operating rooms, isolation rooms, patient care areas and laboratories. When used as directed, it will also effectively clean and decontaminate critical and semi-critical instrumentation. CaviCide does the job of three products, thus saving money by reducing repetitive inventory and time.

Exceptionally fast and effective, CaviCide1™ and CaviWipes1™ are Kerr TotalCare’s next generation EPA- approved surface disinfectants designed to clean and disinfect hard, non-porous surfaces in the dental clinical working environment in 1 minute. Both products offer low alcohol (22.5%) surface disinfection, with clinically-relevant, broad spectrum, microorganism kill claims including: Tuberculosis, HIV-1, HBV, HCV, Influenza H1N1, MRSA, Salmonella enterica, and ESBL E. coli. CaviCide1 and CaviWipes1 do not contain bleach or other toxic chemicals. The non-corrosive products are gentle on surfaces and compatible with most hard, non-porous surfaces. Packaged in convenient, ready-to-use configurations, CaviCide1 and CaviWipes1 are perfect for cleaning, disinfecting and decontaminating environmental surfaces and medical devices.